Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: IMDMC petition

This article was originally published in The Gray Sheet

Executive Summary

IMDMC petition: Rep. David McIntosh (R-Ind.) urges FDA "to move forward" on a response to the Indiana Medical Device Manufacturers Council's May 1995 citizens petition on the agency's use of guidance documents ("The Gray Sheet" May 22, 1995, p. 3). In an Aug. 6 letter to FDA Deputy Commissioner for Policy William Schultz, the Indiana Republican notes that "it has been well over a year" since the trade group submitted its petition and recommends FDA "set a completion date" for the response. In addition, McIntosh asks for a status report on the IMDMC issue, "an outline for FDA's future plan for developing a response to the petition," and a "summary of the anticipated form(s) of FDA's response to the full range of rulemaking and guidance issues raised by the petition." FDA has proposed a series of "good guidance practices" to address several of the issues in the petition ("The Gray Sheet" March 11, I&W-2); the agency hopes to finalize the GGPs before the end of the year. FDA's device center has implemented its own guidance policy until the agency-wide GGPs are completed...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT006596

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel